Sign in to continue:

Thursday, March 5th, 2026

Sino Harbour Holdings Chairman Increases Shareholding with Purchase of 7.19 Million Shares at HK$0.085 Each 1





Sino Harbour Holdings Group Chairman Increases Shareholding

Sino Harbour Holdings Group Chairman Significantly Increases Shareholding

Key Highlights from the Announcement

  • Chairman and Substantial Shareholder, Mr. Wong Lam Ping, has acquired 7,192,000 shares.
  • Acquisition took place in the open market on 5 March 2026.
  • Average purchase price was approximately HK\$0.085 per share, with the highest price at HK\$0.085 per share.
  • Mr. Wong is also the Chief Executive Officer, Executive Director, and General Manager of Sino Harbour Holdings Group Limited.
  • The Board currently comprises eight directors, including four executive directors, one non-executive director, and three independent non-executive directors.

Detailed Analysis for Investors

Sino Harbour Holdings Group Limited has issued a voluntary announcement informing shareholders and potential investors of a significant transaction involving its chairman and substantial shareholder, Mr. Wong Lam Ping. On 5 March 2026, Mr. Wong acquired a total of 7,192,000 ordinary shares in the open market.

The shares were purchased at an average price of HK\$0.085 per share, with the highest price also recorded at HK\$0.085 per share. This price level could indicate confidence in the company’s value at current market levels, especially given the size of the acquisition.

Mr. Wong’s increased shareholding may signal his positive view of the company’s prospects, and such insider buying activity is often interpreted by the market as a bullish signal. It is important to note that Mr. Wong is not only the Chairman but also the Chief Executive Officer, Executive Director, and General Manager of the company. His direct involvement in the management and his willingness to invest further in the company’s shares could influence investor sentiment and potentially impact the share price.

The announcement also reminds shareholders and investors to exercise caution when dealing in the securities of the company. This is a standard warning, but in the context of the substantial purchase by the Chairman, it may be interpreted as an indication of anticipated volatility or significant developments.

The Board of Sino Harbour Holdings Group Limited consists of eight directors, highlighting a diverse leadership structure. The executive directors include Mr. Wong Lam Ping, Mr. Shi Feng (Deputy Chairman), Mr. Wong Lui, and Ms. Gao Lan. There is one non-executive director, Mr. Chan Kin Sang, and three independent non-executive directors, Mr. Xie Gang, Mr. He Dingding, and Mr. Wong Ping Kuen.

Potential Impact on Share Price

The acquisition by Mr. Wong is a price-sensitive event. Substantial insider purchases are closely watched by the market and may result in increased investor confidence, potentially supporting or boosting the share price in the near term. Investors should monitor trading volumes and price movements following this announcement for further signals.

Important Considerations for Shareholders

  • Substantial insider buying is often viewed as a positive indicator for future performance.
  • The purchase price may set a psychological floor for the share price.
  • Investors should remain vigilant for additional announcements or developments.
  • The cautionary note from the board suggests that while the transaction is positive, investors should not disregard other risks.

Disclaimer

This article is for informational purposes only and does not constitute investment advice. Shareholders and investors are advised to conduct their own research or consult with professional advisors before making any investment decisions. The company and its directors accept no responsibility for any loss arising from reliance on this information.




View S HARBOURHOLD Historical chart here



Shanghai Henlius Biotech Doses First Patient in Phase 2/3 Clinical Trial of HLX22 and HLX87 for HER2-Positive Breast Cancer in China 123

Shanghai Henlius Biotech Doses First Patient in Pivotal Phase 2/3 Breast Cancer Study — Key Developments for Investors Shanghai Henlius Biotech Initiates Phase 2/3 Clinical Study for HLX22 and HLX87 in HER2-Positive Breast Cancer...

GoFintech Quantum Innovation Limited Major Acquisition of Artworks and RWA Tokenization Strategy – EGM Notice and Investment Circular

GoFintech Quantum Innovation Limited: Major Artwork Acquisition and Extraordinary General Meeting GoFintech Quantum Innovation Limited Announces Major Acquisition of Artworks and Calls Extraordinary General Meeting Key Highlights for Investors Major Transaction: GoFintech Quantum Innovation...

SSY Group Limited Issues Profit Warning for 2025 with Estimated 45%-60% Decline in Earnings Due to Reduced Turnover and Price Pressure 12

SSY Group Limited Issues Significant Profit Warning for FY2025 SSY Group Limited Issues Significant Profit Warning for FY2025 Key Highlights from the Announcement SSY Group Limited (Stock Code: 2005) expects a substantial reduction in...

   Ad